Compare Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
3.0
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
1.06
1.86
NAV
₹21.07
₹37.96
Fund Started
06 Oct 2020
25 Jun 2018
Fund Size
₹166.85 Cr
₹6658.41 Cr
Exit Load
-
Exit load of 1% if redeemed within 15 days.
1 Year
11.72%
8.03%
3 Year
22.07%
27.09%
5 Year
14.61%
16.93%
Equity
99.82%
97.60%
Cash
-0.09%
2.37%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 10.90% |
Eli Lilly And Co | 6.27% |
Apollo Hospitals Enterprise Ltd. | 5.35% |
Cipla Ltd. | 5.33% |
Max Healthcare Institute Ltd. | 5.30% |
Divi's Laboratories Ltd. | 5.15% |
Dr. Reddy's Laboratories Ltd. | 4.71% |
Johnson & Johnson Ltd. | 4.12% |
Lupin Ltd. | 3.85% |
Torrent Pharmaceuticals Ltd. | 3.34% |
Sun Pharmaceutical Industries Ltd. | 11.20% |
Cipla Ltd. | 9.43% |
Dr. Reddy's Laboratories Ltd. | 7.27% |
Mankind Pharma Ltd. | 6.34% |
Divi's Laboratories Ltd. | 6.22% |
Biocon Ltd. | 5.85% |
Lupin Ltd. | 4.80% |
Aurobindo Pharma Ltd. | 3.91% |
Syngene International Ltd. | 2.99% |
Alkem Laboratories Ltd. | 2.90% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
06 Oct 2020
25 Jun 2018
